Skip Navigation



eCAM Advance Access published online on June 20, 2006
eCAM, doi:10.1093/ecam/nel026
This Article
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
3/3/365    most recent
nel026v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Luo, J. Z.
Right arrow Articles by Luo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J. Z.
Right arrow Articles by Luo, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press. All rights reserved.

Original Article

American Ginseng Stimulates Insulin Production and Prevents Apoptosis through Regulation of Uncoupling Protein-2 in Cultured {beta} Cells

John Zeqi Luo 1 and Luguang Luo 2 *

1 PLME Department of Medicine, Brown University, Providence, RI 02912, USA
2 The Center for Stem Cell Biology, Department of Research, Roger Williams Hospital, Providence, RI 02908, USA

* To whom correspondence should be addressed.
Luguang Luo, E-mail: Lluo{at}rwmc.org


  Abstract

American ginseng root displays the ability to achieve glucose homeostasis both experimentally and clinically but the unknown mechanism used by ginseng to achieve its therapeutic effects on diabetes limits its application. Disruption in the insulin secretion of pancreatic {beta} cells is considered the major cause of diabetes. A mitochondrial protein, uncoupling protein-2 (UCP-2) has been found to play a critical role in insulin synthesis and {beta} cell survival. Our preliminary studies found that the extracts of American ginseng inhibit UCP-2 expression which may contribute to the ability of ginseng protecting {beta} cell death and improving insulin synthesis. Therefore, we hypothesized that ginseng extracts suppress UCP-2 in the mitochondria of pancreatic {beta} cells, promoting insulin synthesis and anti-apoptosis (a programmed cell-death mechanism). To test the hypothesis, the serum-deprived quiescent {beta} cells were cultured with or without interleukin-1{beta} (IL-1{beta}), (200 pg ml-1, a cytokine to induce {beta} cell apoptosis) and water extracts of American ginseng (25 µg per 5 µl administered to wells of 0.5 ml culture) for 24 h. We evaluated effects of ginseng on UCP-2 expression, insulin production, anti-/pro-apoptotic factors Bcl-2/caspase-9 expression and cellular ATP levels. We found that ginseng suppresses UCP-2, down-regulates caspase-9 while increasing ATP and insulin production/secretion and up-regulates Bcl-2, reducing apoptosis. These findings suggest that stimulation of insulin production and prevention of {beta} cell loss by American ginseng extracts can occur via the inhibition of mitochondrial UCP-2, resulting in increase in the ATP level and the anti-apoptotic factor Bcl-2, while down-regulation of pro-apoptotic factor caspase-9 occurs, lowering the occurrence of apoptosis, which support the hypothesis.

Keywords: American ginseng; apoptosis; ATP; {beta} cell; Bcl-2; caspase; insulin; mitochondria; UCP-2.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
J. Z. Luo and L. Luo
Ginseng on Hyperglycemia: Effects and Mechanisms
Evid. Based Complement. Altern. Med., December 1, 2009; 6(4): 423 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
N. Bianchi, C. Zuccato, I. Lampronti, M. Borgatti, and R. Gambari
Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia
Evid. Based Complement. Altern. Med., June 1, 2009; 6(2): 141 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
M. Bhat, S. K. Kothiwale, A. R. Tirmale, S. Y. Bhargava, and B. N. Joshi
Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model
Evid. Based Complement. Altern. Med., April 23, 2009; (2009) nep033v1.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
I. Lampronti, M. T.H. Khan, M. Borgatti, N. Bianchi, and R. Gambari
Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 303 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
K. Chatelain, S. Phippen, J. McCabe, C. A. Teeters, S. O'Malley, and K. Kingsley
Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas
Evid. Based Complement. Altern. Med., July 23, 2008; (2008) nen047v1.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
G. Klein, J. Kim, K. Himmeldirk, Y. Cao, and X. Chen
Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa
Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 401 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
R. Xia, P. Huang, and G.-m. Shao
Nourishing Yin and Promoting Blood Circulation of TCM to Treat Hemorheologic Disorder Induced by Diabetes Mellitus in Rats
Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 203 - 207.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.